Results 51 to 60 of about 8,460 (122)

New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut

, 2010
Inflammatory bowel diseases are chronic diseases that affect the gastrointestinal tract. Mesalamine, corticosteroids, immunosuppressants and biological agents are currently used to treat these diseases.
A. Malesci, G. Fiorino, S. A. De La Rue, S. Danese, A. Repici, W. Fries, A.C. Malesci, S.A. De La Rue   +7 more
core   +1 more source

Oral budesonide for induction of remission in ulcerative colitis

, 2015
BACKGROUND: Corticosteroids are first‐line therapy for induction of remission in ulcerative colitis. Although corticosteroids may improve symptoms, they have significant adverse effects.
A Hillary Steinhart, Sherlock, Mary E, Seow, Cynthia H, Mary E Sherlock, Cynthia H Seow, Griffiths, Anne Marie, John K MacDonald, MacDonald, John K, Anne Marie Griffiths, Steinhart, A Hillary   +9 more
core   +1 more source

Budesonide with multi-matrix technology as second-line treatment for ulcerative colitis: evaluation of long-term cost-effectiveness in the Netherlands

, 2019
Aims: Budesonide with multi-matrix technology (MMX) is an oral corticosteroid, shown to have high topical activity against ulcerative colitis (UC) while maintaining low systemic bioavailability with few adverse events.
Stéphane Roze (4915081), Johan Kuijvenhoven (5439893), Alexandre Gherardi (5439896), Yum Lina Yip Sonderegger (5439890), Ola Ghatnekar (5439899)   +4 more
core   +1 more source

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. [PDF]

, 2014
BACKGROUND: Inhaled corticosteroids (ICS) are anti-inflammatory drugs that have proven benefits for people with worsening symptoms of chronic obstructive pulmonary disease (COPD) and repeated exacerbations.
Seniukovich, A, Alieksei Seniukovich, Kew, KM, Kayleigh M Kew   +3 more
core   +1 more source

Development of novel zero-order release budesonide tablets for the treatment of ileo-colonic inflammatory bowel disease and comparison with formulations currently used in clinical practice [PDF]

, 2020
BACKGROUND: In patients with inflammatory bowel disease, the terminal ileum and colon is the most affected region. Oral budesonide is an effective treatment but in vitro as well as clinical data suggest that the formulations currently used in clinical ...
Kosterink, Jos G.W.; id_orcid, Frijlink, Henderik W.; id_orcid, Gareb, Bahez; id_orcid, Dijkstra, Gerard; id_orcid   +3 more
core   +2 more sources

Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease

, 2016
Ulcerative colitis (UC) and Crohn's disease (CD) are diseases affecting the gastrointestinal tract. Treatment depends on the severity of the disease, site of inflammation, and patient's response.
Frijlink, Hendrik, Gareb, Bahez, Kosterink, Jos G. W.; id_orcid, Kosterink, Jos G. W., Gareb, Bahez; id_orcid, Frijlink, Hendrik; id_orcid, Eissens, Anko C.   +6 more
core   +1 more source

Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children [PDF]

, 2008
BackgroundCombination therapies are frequently recommended as maintenance therapy for people with asthma, whose disease is not adequately controlled with inhaled steroids.
Christopher J Cates, Lasserson, TJ, Giovanni Ferrara, Ferrara, G, Toby J Lasserson, Cates, CJ, Casali, L, Lucio Casali   +7 more
core   +1 more source

Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment

, 2008
Crohn's disease and ulcerative colitis are chronic relapsing inflammatory bowel diseases with extremely great variability in presentation and clinical course.
E. Angelucci, A. Malesci, S. Danese
core   +1 more source

Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children (Review) [PDF]

, 2009
Background Traditionally inhaled treatment for asthma has been considered as preventer and reliever therapy. The combination of formoterol and budesonide in a single inhaler introduces the possibility of using a single inhaler for both prevention and ...
Christopher J Cates, Lasserson, TJ, Toby J Lasserson, Cates, CJ   +3 more
core   +1 more source

Budesonide foam vs. hydrocortisone acetate foam in the treatment of active ulcerative proctosigmoiditis

, 2003
INTRODUCI'ION: Rectal administration of corticosteroids is advocated in patients with proctosigmoiditis who have failed therapy with mesalamine enema. Foam offers patients better tolerability than an enema.
CHOWERS Y, GROBETA V, GROUP, FASZCZYK M, BARMEIR S, STURNIOLO, GIACOMO, BIANCHI PORRO G, MULLER R, GREINWALD R, MICKISCH, O, FIDDER HH, INTERNATIONAL BUDESONIDE STUDY   +11 more
core   +1 more source